Not applicableLooking for participantsNCT05046444What this trial is testingSolving Riddles Through SequencingWho this might be right forLeukemiaHematologic MalignancyRare Diseases+3 more Munich Leukemia Laboratory 100
Testing effectiveness (Phase 2)Study completedNCT00193609What this trial is testingOxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary SiteWho this might be right forNeoplasms, Unknown Primary SCRI Development Innovations, LLC 48
Testing effectiveness (Phase 2)Ended earlyNCT00201734What this trial is testingCapecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown PrimaryWho this might be right forTumorsUnknown Primary TumorsAdenocarcinoma Ohio State University Comprehensive Cancer Center 57
Early research (Phase 1)Looking for participantsNCT06868433What this trial is testingTMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell CancerWho this might be right forClinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more Emory University
Testing effectiveness (Phase 2)Ended earlyNCT00003526What this trial is testingAntineoplaston Therapy in Treating Patients With Cancer of Unknown Primary OriginWho this might be right forUnknown Primary Carcinoma Burzynski Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT00936702What this trial is testingCarboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown PrimaryWho this might be right forCarcinoma of Unknown Primary Origin Alliance for Clinical Trials in Oncology 46
Testing effectiveness (Phase 2)UnknownNCT04131621What this trial is testingNivolumab/Ipilimumab in Second Line CUP-syndromeWho this might be right forCancer of Unknown Primary Site University Hospital Heidelberg 194
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Not applicableUnknownNCT04952103What this trial is testingReal World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in ChinaWho this might be right forCancer of Unknown Primary Site Fudan University 200
Very early researchStudy completedNCT03868020What this trial is testingFluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal DiseaseWho this might be right forMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Squamous Cell Carcinoma in Cervical Lymph Node M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT05024968What this trial is testingSintilimab in Cancer of Unknown PrimaryWho this might be right forCancer of Unknown Primary Site M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT03628079What this trial is testingA Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.Who this might be right forCancer of the Gastrointestinal TractCancer of Unknown Origin Repos Pharma 11
Not applicableStudy completedNCT02628379What this trial is testingOutcomes of FoundationOne Directed Therapy in Cancer of Unknown PrimaryWho this might be right forNeoplasms, Unknown PrimaryCUPMetastatic Disease+3 more Foundation Medicine 125
Testing effectiveness (Phase 2)Looking for participantsNCT05576974What this trial is testingA Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)Who this might be right forHead and Neck CancerUnknown Primary CancerHead and Neck Squamous Cell Carcinoma University of Texas Southwestern Medical Center 120
Not applicableLooking for participantsNCT04475640What this trial is testingCancer Genetic Testing in Ethnic PopulationsWho this might be right forBreast CarcinomaCarcinoma of Unknown PrimaryCentral Nervous System Carcinoma+8 more Mayo Clinic 1,800
Large-scale testing (Phase 3)UnknownNCT00022178What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of OriginWho this might be right forCarcinoma of Unknown Primary The Christie NHS Foundation Trust
Testing effectiveness (Phase 2)UnknownNCT02590055What this trial is testingPhase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown PrimaryWho this might be right forCarcinoma of Unknown Primary Samsung Medical Center 29
Not applicableLooking for participantsNCT02906943What this trial is testingOntario-wide Cancer TArgeted Nucleic Acid EvaluationWho this might be right forBreast CancerLung CancerColorectal Cancer+8 more University Health Network, Toronto 10,000
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Not applicableUnknownNCT06100081What this trial is testingReal-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and NeckWho this might be right forUnknown Primary TumorsOropharynx Cancer University Medical Center Groningen 35